Literature DB >> 15633900

Management of hemorrhagic high jugular bulb with adhesive otitis media in an only hearing ear: transcatheter endovascular embolization using detachable coils.

Kazumasa Kondoh1, Tadashi Kitahara, Yasuo Mishiro, Shin-ichi Okumura, Takeshi Kubo.   

Abstract

A 51-year-old woman had a hemorrhagic high jugular bulb protruding into the posterosuperior part of the tympanic cavity in her left ear. This (only hearing) ear had severe adhesive otitis media resulting in repetitive hemorrhage from the jugular bulb. Therefore, treatment to stop the bleeding was required. Since invasive middle ear surgery in an only hearing ear would involve a high risk of hearing loss and massive bleeding, transcatheter endovascular embolization using detachable coils was selected for this special case; it safely blocked the blood flow and preserved the patient's hearing level. This is the first such report in the otosurgical field, showing that transcatheter endovascular embolization using detachable coils was quite effective in a difficult case of a hemorrhagic high jugular bulb with severe adhesive otitis media in an only hearing ear.

Entities:  

Mesh:

Year:  2004        PMID: 15633900     DOI: 10.1177/000348940411301207

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  3 in total

Review 1.  Surgical treatment of the high jugular bulb by compressing sinus sigmoideus: two cases.

Authors:  Sedat Oztürkcan; Hüseyin Katilmiş; Yilmaz Ozkul; Nezahat Erdoğan; Sinan Başoğlu; Mehmet Ali Tayfun
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-29       Impact factor: 2.503

2.  Encountering a high jugular bulb during ear surgery.

Authors:  R Fox; R Nash; T Tatla
Journal:  Ann R Coll Surg Engl       Date:  2016-09-23       Impact factor: 1.891

3.  Single-center 10-year experience in treating patients with vascular tinnitus: diagnostic approaches and treatment outcomes.

Authors:  Seong Cheon Bae; Dong Kee Kim; Sang Won Yeo; So Young Park; Shi Nae Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-02-03       Impact factor: 3.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.